People: AcelRx Pharmaceuticals Inc (ACRX.O)

ACRX.O on Consolidated Issue listed on NASDAQ Global Market

7.15USD
29 Aug 2014
Price Change (% chg)

$0.03 (+0.42%)
Prev Close
$7.12
Open
$7.15
Day's High
$7.33
Day's Low
$7.01
Volume
415,092
Avg. Vol
1,155,981
52-wk High
$13.64
52-wk Low
$6.04

Search Stocks

Wan, Mark 

Brief Biography

Mr. Mark Allen Wan is an Independent Director of AcelRx Pharmaceuticals Inc. Mr. Wan is a founding general partner of Three Arch Partners, a venture capital firm. Prior to co-founding Three Arch Partners in 1993, Mr. Wan was a general partner at Brentwood Associates, a private equity firm from 1987 until 1993. Since 1999, Mr. Wan has served on the board of directors of Epocrates, Inc., a company focused on providing mobile drug reference tools. Mr. Wan also serves on the board of directors of numerous private companies. Mr. Wan holds a B.S. in Engineering from Yale University and an M.B.A. from the Stanford Graduate School of Business.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Adrian Adams

--

Richard King

2,623,920

Timothy Morris

--

Pamela Palmer

2,015,870

Badri Dasu

914,083

Lawrence Hamel

508,560
As Of 30 Dec 2013
Search Stocks